Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CampETEC by Immuron for Campylobacter Infections: Likelihood of Approval
CampETEC is under clinical development by Immuron and currently in Phase II for Campylobacter Infections. According to GlobalData, Phase II...